Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

N-terminal domain of the murine coronavirus receptor CEACAM1 is responsible for fusogenic activation and conformational changes of the spike protein.

Identifieur interne : 005229 ( Main/Exploration ); précédent : 005228; suivant : 005230

N-terminal domain of the murine coronavirus receptor CEACAM1 is responsible for fusogenic activation and conformational changes of the spike protein.

Auteurs : Hideka S. Miura [Japon] ; Keiko Nakagaki ; Fumihiro Taguchi

Source :

RBID : pubmed:14671103

Descripteurs français

English descriptors

Abstract

The mouse hepatitis virus (MHV) receptor (MHVR), CEACAM1, has two different functions for MHV entry into cells: binding to MHV spike protein (S protein) and activation of the S protein to execute virus-cell membrane fusion, the latter of which is accompanied by conformational changes of the S protein. The MHVR comprising the N-terminal and fourth domains [R1(1,4)] displays these two activities, and the N domain is thought to be critical for binding to MHV. In this study, we have addressed whether or not the N domain alone is sufficient for these activities. We examined three types of soluble form MHVR (soMHVR), one consisting of the N domain alone [soR1(1)], one with the N and second domains [soR1(1,2)], and one [soR1(1,4)] expressed by recombinant baculoviruses. We assessed the abilities of these three types of soMHVR to bind to MHV, activate fusogenicity, and induce conformational changes of the S protein. All three types of soMHVR similarly bound to MHV, as examined by a solid-phase binding assay and neutralized MHV infectivity. They also activated S protein fusogenicity and induced its conformational changes with similar levels of efficiency. However, R1(1) expressed on the BHK cell surface failed to serve as a receptor in spite of a sufficient level of expression. The inability of expressed R1(1) to work as a receptor was due to the inaccessibility of virions to R1(1); however, these were accessible using the MHVR-specific monoclonal antibody CC1. These results collectively indicated that the N domain retains all biological activities necessary for receptor function.

DOI: 10.1128/jvi.78.1.216-223.2004
PubMed: 14671103


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">N-terminal domain of the murine coronavirus receptor CEACAM1 is responsible for fusogenic activation and conformational changes of the spike protein.</title>
<author>
<name sortKey="Miura, Hideka S" sort="Miura, Hideka S" uniqKey="Miura H" first="Hideka S" last="Miura">Hideka S. Miura</name>
<affiliation wicri:level="1">
<nlm:affiliation>National Institute of Neuroscience, NCNP, Kodaira, Tokyo 187-8502, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>National Institute of Neuroscience, NCNP, Kodaira, Tokyo 187-8502</wicri:regionArea>
<placeName>
<settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Nakagaki, Keiko" sort="Nakagaki, Keiko" uniqKey="Nakagaki K" first="Keiko" last="Nakagaki">Keiko Nakagaki</name>
</author>
<author>
<name sortKey="Taguchi, Fumihiro" sort="Taguchi, Fumihiro" uniqKey="Taguchi F" first="Fumihiro" last="Taguchi">Fumihiro Taguchi</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2004">2004</date>
<idno type="RBID">pubmed:14671103</idno>
<idno type="pmid">14671103</idno>
<idno type="doi">10.1128/jvi.78.1.216-223.2004</idno>
<idno type="wicri:Area/PubMed/Corpus">003047</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003047</idno>
<idno type="wicri:Area/PubMed/Curation">003047</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003047</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002B78</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002B78</idno>
<idno type="wicri:Area/Ncbi/Merge">000502</idno>
<idno type="wicri:Area/Ncbi/Curation">000502</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000502</idno>
<idno type="wicri:doubleKey">0022-538X:2004:Miura H:n:terminal:domain</idno>
<idno type="wicri:Area/Main/Merge">005621</idno>
<idno type="wicri:Area/Main/Curation">005229</idno>
<idno type="wicri:Area/Main/Exploration">005229</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">N-terminal domain of the murine coronavirus receptor CEACAM1 is responsible for fusogenic activation and conformational changes of the spike protein.</title>
<author>
<name sortKey="Miura, Hideka S" sort="Miura, Hideka S" uniqKey="Miura H" first="Hideka S" last="Miura">Hideka S. Miura</name>
<affiliation wicri:level="1">
<nlm:affiliation>National Institute of Neuroscience, NCNP, Kodaira, Tokyo 187-8502, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>National Institute of Neuroscience, NCNP, Kodaira, Tokyo 187-8502</wicri:regionArea>
<placeName>
<settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Nakagaki, Keiko" sort="Nakagaki, Keiko" uniqKey="Nakagaki K" first="Keiko" last="Nakagaki">Keiko Nakagaki</name>
</author>
<author>
<name sortKey="Taguchi, Fumihiro" sort="Taguchi, Fumihiro" uniqKey="Taguchi F" first="Fumihiro" last="Taguchi">Fumihiro Taguchi</name>
</author>
</analytic>
<series>
<title level="j">Journal of virology</title>
<idno type="ISSN">0022-538X</idno>
<imprint>
<date when="2004" type="published">2004</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals</term>
<term>Antigens, CD (chemistry)</term>
<term>Antigens, CD (metabolism)</term>
<term>Antigens, Differentiation (chemistry)</term>
<term>Antigens, Differentiation (metabolism)</term>
<term>Carcinoembryonic Antigen</term>
<term>Cell Adhesion Molecules</term>
<term>Cell Line</term>
<term>Cell Membrane (metabolism)</term>
<term>Cricetinae</term>
<term>Flow Cytometry</term>
<term>Membrane Fusion</term>
<term>Membrane Glycoproteins (chemistry)</term>
<term>Membrane Glycoproteins (metabolism)</term>
<term>Murine hepatitis virus (metabolism)</term>
<term>Murine hepatitis virus (pathogenicity)</term>
<term>Murine hepatitis virus (physiology)</term>
<term>Neutralization Tests</term>
<term>Protein Conformation</term>
<term>Receptors, Virus (chemistry)</term>
<term>Receptors, Virus (metabolism)</term>
<term>Spike Glycoprotein, Coronavirus</term>
<term>Structure-Activity Relationship</term>
<term>Viral Envelope Proteins (chemistry)</term>
<term>Viral Envelope Proteins (metabolism)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Animaux</term>
<term>Antigène carcinoembryonnaire</term>
<term>Antigènes CD ()</term>
<term>Antigènes CD (métabolisme)</term>
<term>Antigènes de différenciation ()</term>
<term>Antigènes de différenciation (métabolisme)</term>
<term>Conformation des protéines</term>
<term>Cricetinae</term>
<term>Cytométrie en flux</term>
<term>Fusion membranaire</term>
<term>Glycoprotéine de spicule des coronavirus</term>
<term>Glycoprotéines membranaires ()</term>
<term>Glycoprotéines membranaires (métabolisme)</term>
<term>Lignée cellulaire</term>
<term>Membrane cellulaire (métabolisme)</term>
<term>Molécules d'adhérence cellulaire</term>
<term>Protéines de l'enveloppe virale ()</term>
<term>Protéines de l'enveloppe virale (métabolisme)</term>
<term>Relation structure-activité</term>
<term>Récepteurs viraux ()</term>
<term>Récepteurs viraux (métabolisme)</term>
<term>Tests de neutralisation</term>
<term>Virus de l'hépatite murine (métabolisme)</term>
<term>Virus de l'hépatite murine (pathogénicité)</term>
<term>Virus de l'hépatite murine (physiologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en">
<term>Antigens, CD</term>
<term>Antigens, Differentiation</term>
<term>Membrane Glycoproteins</term>
<term>Receptors, Virus</term>
<term>Viral Envelope Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Antigens, CD</term>
<term>Antigens, Differentiation</term>
<term>Membrane Glycoproteins</term>
<term>Receptors, Virus</term>
<term>Viral Envelope Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Cell Membrane</term>
<term>Murine hepatitis virus</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Antigènes CD</term>
<term>Antigènes de différenciation</term>
<term>Glycoprotéines membranaires</term>
<term>Membrane cellulaire</term>
<term>Protéines de l'enveloppe virale</term>
<term>Récepteurs viraux</term>
<term>Virus de l'hépatite murine</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en">
<term>Murine hepatitis virus</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr">
<term>Virus de l'hépatite murine</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr">
<term>Virus de l'hépatite murine</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>Murine hepatitis virus</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Carcinoembryonic Antigen</term>
<term>Cell Adhesion Molecules</term>
<term>Cell Line</term>
<term>Cricetinae</term>
<term>Flow Cytometry</term>
<term>Membrane Fusion</term>
<term>Neutralization Tests</term>
<term>Protein Conformation</term>
<term>Spike Glycoprotein, Coronavirus</term>
<term>Structure-Activity Relationship</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Animaux</term>
<term>Antigène carcinoembryonnaire</term>
<term>Antigènes CD</term>
<term>Antigènes de différenciation</term>
<term>Conformation des protéines</term>
<term>Cricetinae</term>
<term>Cytométrie en flux</term>
<term>Fusion membranaire</term>
<term>Glycoprotéine de spicule des coronavirus</term>
<term>Glycoprotéines membranaires</term>
<term>Lignée cellulaire</term>
<term>Molécules d'adhérence cellulaire</term>
<term>Protéines de l'enveloppe virale</term>
<term>Relation structure-activité</term>
<term>Récepteurs viraux</term>
<term>Tests de neutralisation</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The mouse hepatitis virus (MHV) receptor (MHVR), CEACAM1, has two different functions for MHV entry into cells: binding to MHV spike protein (S protein) and activation of the S protein to execute virus-cell membrane fusion, the latter of which is accompanied by conformational changes of the S protein. The MHVR comprising the N-terminal and fourth domains [R1(1,4)] displays these two activities, and the N domain is thought to be critical for binding to MHV. In this study, we have addressed whether or not the N domain alone is sufficient for these activities. We examined three types of soluble form MHVR (soMHVR), one consisting of the N domain alone [soR1(1)], one with the N and second domains [soR1(1,2)], and one [soR1(1,4)] expressed by recombinant baculoviruses. We assessed the abilities of these three types of soMHVR to bind to MHV, activate fusogenicity, and induce conformational changes of the S protein. All three types of soMHVR similarly bound to MHV, as examined by a solid-phase binding assay and neutralized MHV infectivity. They also activated S protein fusogenicity and induced its conformational changes with similar levels of efficiency. However, R1(1) expressed on the BHK cell surface failed to serve as a receptor in spite of a sufficient level of expression. The inability of expressed R1(1) to work as a receptor was due to the inaccessibility of virions to R1(1); however, these were accessible using the MHVR-specific monoclonal antibody CC1. These results collectively indicated that the N domain retains all biological activities necessary for receptor function.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Japon</li>
</country>
<region>
<li>Région de Kantō</li>
</region>
<settlement>
<li>Tokyo</li>
</settlement>
</list>
<tree>
<noCountry>
<name sortKey="Nakagaki, Keiko" sort="Nakagaki, Keiko" uniqKey="Nakagaki K" first="Keiko" last="Nakagaki">Keiko Nakagaki</name>
<name sortKey="Taguchi, Fumihiro" sort="Taguchi, Fumihiro" uniqKey="Taguchi F" first="Fumihiro" last="Taguchi">Fumihiro Taguchi</name>
</noCountry>
<country name="Japon">
<region name="Région de Kantō">
<name sortKey="Miura, Hideka S" sort="Miura, Hideka S" uniqKey="Miura H" first="Hideka S" last="Miura">Hideka S. Miura</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005229 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 005229 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:14671103
   |texte=   N-terminal domain of the murine coronavirus receptor CEACAM1 is responsible for fusogenic activation and conformational changes of the spike protein.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:14671103" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021